⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103201 | 1.00 | — | — | |
| SCHEMBL103202 | 1.00 | — | — | |
| SCHEMBL27962467 | 0.98 | NR4A1 (0.59) | — | |
| Hydrochloric Acid SCHEMBL10825098 | 0.98 | NR4A1 (0.59) | — | |
| SCHEMBL3889364 | 0.98 | NR4A1 (0.59) | — | |
| Hydrochloric Acid SCHEMBL28427030 | 0.98 | NR4A1 (0.59) | — | |
| SCHEMBL29119568 | 0.98 | NR4A1 (0.59) | — | |
| SCHEMBL30800889 | 0.98 | NR4A1 (0.59) | — | |
| Iodomethane SCHEMBL366129 | 0.94 | NR4A1 (0.55) | — | |
| Chloromethane SCHEMBL1169195 | 0.94 | NR4A1 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106279024-B | A kind of xanthine oxidoreductase inhibitors and the preparation method and application thereof | 华南理工大学 | 2018-09-14 | — | — | CN | claimed |
| CN-106279024-A | A kind of xanthine oxidoreductase inhibitors and preparation method and application | 华南理工大学 | 2017-01-04 | — | — | CN | claimed |
| US-6599370-B2 | Stabilized alkaline compositions for cleaning microelectronic substrates | MALLINCKRODT INC. | 2003-07-29 | — | — | US | claimed |
| US-20250296933-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-09-25 | — | — | US | disclosed |
| EP-3768834-B1 | NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF | CRISPR THERAPEUTICS AG (CH) | 2025-08-13 | — | — | EP | disclosed |
| US-12370263-B2 | Cyclic dinucleotide derivative based antibody-drug conjugates | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-07-29 | — | — | US | disclosed |
| CN-119707962-A | Aza four-membered ring connected pyrazolopyridine compound or pharmaceutically acceptable salt thereof and application thereof | 中山大学 | 2025-03-28 | — | — | CN | disclosed |
| EP-4524154-A2 | ANTIBODY-DRUG CONJUGATES OF CYCLIC DINUCLEOTIDE DERIVATIVES | Daiichi Sankyo Company, Limited (JP) | 2025-03-19 | — | — | EP | disclosed |
| EP-4139287-B1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AG (DE) | 2025-02-26 | — | — | EP | disclosed |
| WO-2025036467-A1 | CIRCULAR RNA WITH INCREASED STABILITY AND EXPRESSION | WUHAN UNIVERSITY (CN) | 2025-02-20 | — | — | WO | disclosed |
| EP-3848054-B1 | ANTIBODY-DRUG CONJUGATES OF CYCLIC DINUCLEOTIDE DERIVATIVES | DAIICHI SANKYO CO LTD (JP) | 2025-01-29 | — | — | EP | disclosed |
| WO-2002032919-A2 | 6-O-SUBSTITUTED ERYTHROMYCIN DERIVATIVES HAVING IMPROVED GASTROINTESTINAL TOLERANCE | ABBOTT LABORATORIES (US) | 2002-04-25 | — | — | WO | disclosed |
| US-6056939-A | Self-assembling heteropolymetallic chelates as imaging agents and radiopharmaceuticals | BRACCO IMAGING S.P.A. (IT) | 2000-05-02 | — | — | US | disclosed |
| US-5972959-A | Oxime derivatives, their preparation and their therapeutic use | SANKYO COMPANY, LIMITED (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0708098-B1 | Oxime derivatives, their preparation and their therapeutic use | SANKYO CO (JP) | 1999-03-03 | — | — | EP | disclosed |
| US-5780490-A | A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS | SANKYO COMPANY, LIMITED (JP) | 1998-07-14 | — | — | US | disclosed |
| US-5703096-A | ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR | SANKYO COMPANY, LIMITED (JP) | 1997-12-30 | — | — | US | disclosed |
| EP-0708098-A1 | Oxime derivatives, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |
| US-4950745-A | Process for synthesis of oligonucleotides and compound for forming polymeric protecting group | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1990-08-21 | — | — | US | disclosed |
| US-3957805-A | TREATMENT OF PAIN, MUSCLE SPASMS, ANXIETY, INFLAMMATION, OR TENSION | AMERICAN CYANAMID COMPANY (US) | 1976-05-18 | — | — | US | disclosed |